NRC spin-off develops rapid sensors

IatroQuest Corporation, an Ottawa company spun off from the National Research Council (NRC), has made significant advances in developing rapid sensing and diagnostic systems for the detection and identification of chemical and biological warfare (CBW) agents. Tomorrow, the company's directions will be highlighted at the 6th Annual Ottawa Life Sciences Council National Conference.

IatroQuest Co-Founders, Drs. David Armstrong and Martine Lafrance, will be speaking of the ever increasing global need for CBW agent detection technology. The company's focus is on developing next generation bio-sensing and ultra high throughput diagnostic systems for the defence, medical and occupational health sectors. Less than a year old, IatroQuest has already captured the attention of major players in industry and government.

Currently IatroQuest has patents pending world-wide for its Bio-Alloy™ platform technology. "This breakthrough technology combines elements of biotechnology with advanced materials yielding unique properties" explained Dr. Armstrong, President and CEO of IatroQuest. Bio-Alloy™ can be customized to meet the sensing requirements for military and civil defence, medical and environmental applications. "The technology lends itself to be used in miniaturized, portable, biosensing devices that can be used in defence theaters for real time CBW agent detection and identification allowing for prompt and appropriate countermeasures to be taken," added Dr. Lafrance, Vice-President and Chief Technology Officer.

IatroQuest was founded in January 1999 by Drs. Armstrong and Lafrance, former biomedical Research Officers at NRC. The company is now expanding its workforce and senior management team in order to penetrate the lucrative markets in the defence, medical and occupational health/environmental sectors.


Contact: Sandra Crossfield
National Research Council of Canada

Page: 1

Related biology news :

1. Clemson University spin-off uses corn to make plastics, provide cleaner air
2. New drug discovery spin-off from CSIRO
3. Carnegie Mellon neuroscientist develops tool to image brain function at the cellular level
4. Carnegie Mellon U. develops microgel to recover enzymes for manufacturing, research assays
5. Scientists findings may lead to better understanding of how that sleep develops, matures
6. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
7. US develops lethal new viruses
8. Brookhaven Lab develops ThraxVac to clean up anthrax
9. Carnegie Mellon develops new process for growing bone
10. Cancer could be caught before it develops
11. St. Jude develops vaccine against potential pandemic influenza virus H5N1 using reverse genetics

Post Your Comments:

(Date:8/26/2020)... LUXEMBOURG (PRWEB) , ... August ... ... Luxembourg-based clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with ... of enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ...
(Date:8/26/2020)... , ... August 25, 2020 , ... Modality Solutions, ... Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking ... 2019 as well, and for this year’s list, reported three-year revenue growth of 71 ...
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... that can combine up to three different materials for use with CRM, neurostimulation, ... up to three materials to meet specific design requirements, performance, and cost criteria; ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed ... Manager Regulatory Solutions, in a one hour live webinar on Thursday, August ... in China for drugs and medical devices. Specifically, for medical devices, the NMPA has ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
Breaking Biology Technology:
Cached News: